Particle News: Latest Gastric inhibitory polypeptide news

Irisin-Like Proteins From Gut Bacteria Enter First Human Trials

GutCRINE is recruiting healthy participants to test the safety of live RORDEP-producing bacteria alongside RORDEP1 protein administration.

Tirzepatide Cuts Obesity-Linked Breast Tumor Growth in Mice, Studies Advance Toward Human Trials

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Study Highlights Distinct Metabolic Effects of Tirzepatide and Semaglutide in Obesity Treatment

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

Roche's Experimental Obesity Drug CT-388 Shows Significant Weight Loss in Early Trials

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies

FDA Approves New Weight-Loss Drug Zepbound Amid Reports of Counterfeit Weight-Loss Medications